Review Review: Stimulant Augmentation with Antidepressant in Elderly Patients with Major Depressive Disorder

Stimulant Augmentation with Antidepressant in Elderly Patients with Major Depressive Disorder

Depression in elderly, SSRIs, Resentence, Stimulant augmentation

Authors

Vol. 9 No. 02 (2021)
Medical Sciences and Pharmacy
February 12, 2021

Downloads

According to the Centers for Disease Control and Prevention (CDC), depression affects about 1%-5% of the general elderly population, 13.5% in elderly who require home healthcare, and 11.5% in older hospital patients” CDC, 2017. Depression in the elderly is accompanied by functional weakening and early death due to suicide and other causes, Symptoms may include sadness; lack of interest, power, and ability to concentrate; insomnia and decreased appetite; and co-disease. Elderly patients have a lower response to antidepressant medications than adult patients.